Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Benzinga's options scanner has just identified more than 8 option transactions on DexCom (NASDAQ:DXCM), with a cumulative value of $548,553. Concurrently, our algorithms picked up 5 puts, worth a total of 372,044.
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $97.5 to $131.0 for DexCom over the recent three months.
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for DexCom's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of DexCom's whale trades within a strike price range from $97.5 to $131.0 in the last 30 days.
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|
DXCM | PUT | TRADE | BULLISH | 03/22/24 | $131.00 | $252.8K | 56 | 1.0K |
DXCM | CALL | SWEEP | BULLISH | 04/19/24 | $123.00 | $129.9K | 0 | 14 |
DXCM | CALL | SWEEP | BEARISH | 01/16/26 | $125.00 | $53.4K | 175 | 14 |
DXCM | CALL | TRADE | BULLISH | 01/17/25 | $130.00 | $46.6K | 269 | 20 |
DXCM | PUT | SWEEP | BULLISH | 03/22/24 | $131.00 | $34.3K | 56 | 0 |
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
After a thorough review of the options trading surrounding DexCom, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $165.0.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for DexCom with Benzinga Pro for real-time alerts.
Posted In: DXCM